We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Colorimetric Assay Quantifies Urease Activity

By LabMedica International staff writers
Posted on 13 Nov 2013
A novel high throughput colorimetric urease activity assay was compared to the Nessler method and the new method employs phenol red to determine the urease activity.

This method is rapid, sensitive, easy, cost-effective, does not use any toxic chemical reagents, significantly reduces sample-processing time, and allows real-time investigations. More...


Scientists at the University of Houston (TX, USA) determine the urease activity of seven urease-positive (+) and two urease-negative (−) bacteria from diverse environmental sources. All cultures were incubated for 24 hours at 150 rpm (INNOVA 44, New Brunswick Scientific Co.; Enfield, CT, USA) in their specific growth conditions. The bacterial cells were then adjusted to an optical density of 0.5 at 600 nm with a plate reader.

Suspensions for all microorganisms were inoculated into Stuart's broth in triplicates into flat-bottom 96-well plate and read at 430 nm and 560 nm every 30 minutes for 24 hours with the Synergy MX Microtiter plate reader (BioTek; Winooski, VT, USA). To quantify the urease activity with this new method, the reaction rates were calculated from the absorbance data and they were correlated with the urease activity based on the standard curve of the urease enzyme. The results of this method were compared to the standard Nessler method.

The two methods showed related but not identical values. The Nessler method requires sample collection and preparation steps before measurement of the enzyme activity, but the new method does not, which could explain the slightly different results. In addition, it was found that filtration affects the enzymatic activity, which might be another possible cause for the observed variation between the two results.

The authors concluded that the new method is high throughput, it has decreased analysis processing, and provides a shorter assay work-up. These features make this method a good alternative to the Nessler method for rapid quantification and screening of urease activity. The study was published on October 5, 2103, in the Journal of Microbiological Methods.

Related Links:

University of Houston
New Brunswick Scientific Co. 
BioTek 



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining System
RAL DIFF-QUIK
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.